Skip to main content

OCTREOTIDE

Tracking # 20-813997

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

OCTREOTIDE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF ACROMEGALY AND THYROTROPHINOMAS. IT IS IN THE SOMATOSTATIN ANALOG CLASS OF DRUGS. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR OCTREOTIDE AS A VALUABLE AGENT IN THE MANAGEMENT OF ACROMEGALY AND THYROTROPHINOMAS, AS WELL AS CARCINOID SYNDROME. THIS ACTIVITY ALSO HIGHLIGHTS THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH ENDOCRINOPATHIES AND RELATED CONDITIONS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I